| 000 | 01037 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250514061203.0 | ||
| 264 | 0 | _c20030811 | |
| 008 | 200308s 0 0 eng d | ||
| 022 | _a0391-4097 | ||
| 024 | 7 |
_a10.1007/BF03345130 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLaron, Z | |
| 245 | 0 | 0 |
_aIntranasally and orally active GH secretagogues are useful clinical tools: so why are they not on the market? _h[electronic resource] |
| 260 |
_bJournal of endocrinological investigation _cJan 2003 |
||
| 300 |
_a91-2 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdministration, Intranasal |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aGrowth Hormone _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMarketing of Health Services |
| 650 | 0 | 4 |
_aOligopeptides _xadministration & dosage |
| 773 | 0 |
_tJournal of endocrinological investigation _gvol. 26 _gno. 1 _gp. 91-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF03345130 _zAvailable from publisher's website |
| 999 |
_c12398958 _d12398958 |
||